Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 1/2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Neoplasms 282Carcinoma, Non-Small-Cell Lung 253Leukemia, Myeloid, Acute 190Breast Neoplasms 153Melanoma 151Neoplasm Metastasis 148Multiple Myeloma 127Recurrence 123Colorectal Neoplasms 119Lymphoma, Non-Hodgkin 114Lymphoma 113Leukemia, Lymphocytic, Chronic, B-Cell 108Pancreatic Neoplasms 99Ovarian Neoplasms 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 91Leukemia 86Prostatic Neoplasms 83Lung Neoplasms 82Lymphoma, Large B-Cell, Diffuse 77Squamous Cell Carcinoma of Head and Neck 76Glioblastoma 73Carcinoma, Renal Cell 72Myelodysplastic Syndromes 68Lymphoma, Follicular 65Brain Neoplasms 60Lymphoma, Mantle-Cell 55Sarcoma 53Stomach Neoplasms 52Head and Neck Neoplasms 52Triple Negative Breast Neoplasms 51

Interventions

eltrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Neoplasms, Connective and Soft Tissue × Clear all
NCT02602067 2018-09-18

Tenatumomab

sigma-tau i.f.r. S.p.A.

Phase 1 Terminated
2 enrolled
BreastDermatologicGastrointestinalHead & NeckLymphoid

Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Lymphoma, Non-Hodgkin, Pancreatic Neoplasms, Respiratory Tract Neoplasms, Skin Neoplasms, Urogenital Neoplasms, Neoplasms, Connective and Soft Tissue

NCT01491594 2014-04-02

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Duke University

Phase 1 Terminated
1 enrolled
Sarcoma

Bone Neoplasms, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡